Cargando…
Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes
BACKGROUND: National Comprehensive Cancer Network (NCCN) recently recommended germline genetic testing for all pancreatic cancer patients. However, the genes targeted by genetic testing and the feasibility of selecting patients likely to carry pathogenic variants have not been sufficiently verified....
Autores principales: | Mizukami, Keijiro, Iwasaki, Yusuke, Kawakami, Eiryo, Hirata, Makoto, Kamatani, Yoichiro, Matsuda, Koichi, Endo, Mikiko, Sugano, Kokichi, Yoshida, Teruhiko, Murakami, Yoshinori, Nakagawa, Hidewaki, Spurdle, Amanda B., Momozawa, Yukihide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519363/ https://www.ncbi.nlm.nih.gov/pubmed/32980694 http://dx.doi.org/10.1016/j.ebiom.2020.103033 |
Ejemplares similares
-
Association between germline pathogenic variants in cancer‐predisposing genes and lymphoma risk
por: Usui, Yoshiaki, et al.
Publicado: (2022) -
Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls
por: Momozawa, Yukihide, et al.
Publicado: (2019) -
Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants
por: Momozawa, Yukihide, et al.
Publicado: (2022) -
Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls
por: Momozawa, Yukihide, et al.
Publicado: (2018) -
Unique roles of rare variants in the genetics of complex diseases in humans
por: Momozawa, Yukihide, et al.
Publicado: (2020)